Post treatment CIN: Randomised Controlled Trial using hrHPV-testing for prediction of recurrent or residual disease.
Completed
- Conditions
- Post treatment CIN, cytology and hrHPV testing.
- Registration Number
- NL-OMON26752
- Lead Sponsor
- Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. phone:+31-10-4633381Email: t.helmerhorst@erasmusmc.nlFax: +31-10-4633315
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 204
Inclusion Criteria
Women indicated to be treated for high-grade CIN lesions.
Exclusion Criteria
1. Previous treatment for high-grade CIN;
2. An immune compromised state;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method